Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study

BACKGROUND: The aim of this study was to assess the efficacy and safety of a combination regimen of capecitabine plus cisplatin (CC) or capecitabine plus paclitaxel (CP) as a first-line treatment in patients with metastatic esophageal squamous cell carcinoma. METHODS: Patients with recurrent or meta...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Lee, Su Jin, Kim, Sungmin, Kim, Moonjin, Lee, Jeeyun, Park, Yeon Hee, Im, Young-Hyuck, Park, Se Hoon
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4606554/
https://ncbi.nlm.nih.gov/pubmed/26468007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1716-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars